loading page

Any association between pediatric B-Cell Lymphoblastic Leukemia following SARS-CoV-2 infection: a case series
  • +3
  • Ananya Datta Mitra,
  • Anupam Mitra,
  • Alexander Ladenheim,
  • Kaitlyn Lauren Honeychurch,
  • Denis Dwyre,
  • John Graff
Ananya Datta Mitra
University of California Davis Medical Center
Author Profile
Anupam Mitra
University of California Davis Medical Center
Author Profile
Alexander Ladenheim
University of California Davis Medical Center
Author Profile
Kaitlyn Lauren Honeychurch
University of California Davis Medical Center
Author Profile
Denis Dwyre
University of California Davis Medical Center
Author Profile
John Graff
University of California Davis Medical Center

Corresponding Author:[email protected]

Author Profile

Abstract

COVID-19 infection is still a mystery in terms of its long-term effect on health and its consequences on hematological disorders. In this article, we are presenting two cases of pediatric B-lymphoblastic leukemia (B-ALL) with a previous history of COVID-19 infection. Notably, in both the cases the fluorescence-in situ hybridization (FISH) studies showed pathologic alteration of the RUNX1 gene. The finding of this genetic alteration along with known pre-leukemic translocation ETV6-RUNX1, opens a door for further exploration of the “second-hit” hypothesis regarding an infectious agent precipitating development of B-ALL in a genetically susceptible individual.